Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGP-15 add-on therapy in type 2 diabetes mellitus
2009-013328-21Phase 2Terminated
- Sponsor
- N-Gene Research & Development
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BGP-15 in type 2 diabetes mellitus (T2DM) (6 arms), sponsored by N-Gene Research & Development. Primary endpoint: Change in glycated hemoglobin. Started Jan 2011; status: terminated.
02
Drugs
BGP-15
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-013328-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013328-21.